4.1 Article

Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism

Joanne Trinh et al.

NEUROBIOLOGY OF AGING (2014)

Article Clinical Neurology

Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations

Roy N. Alcalay et al.

MOVEMENT DISORDERS (2013)

Article Genetics & Heredity

Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and Interest

Dana Clay Falcone et al.

JOURNAL OF GENETIC COUNSELING (2011)

Letter Clinical Neurology

Kin-Cohort Analysis of LRRK2-G2019S Penetrance in Parkinson's Disease

Stefano Goldwurm et al.

MOVEMENT DISORDERS (2011)

Article Medicine, General & Internal

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

E. Sidransky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Clinical Neurology

Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy

N. Dahodwala et al.

PARKINSONISM & RELATED DISORDERS (2007)

Article Clinical Neurology

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease

L. N. Clark et al.

NEUROLOGY (2006)

Review Clinical Neurology

Genetic testing in Parkinson disease - Promises and pitfalls

Eng-King Tan et al.

ARCHIVES OF NEUROLOGY (2006)

Article Clinical Neurology

Accuracy of family history data on Parkinson's disease

K Marder et al.

NEUROLOGY (2003)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY